Another study demonstrated that PDK4 is substantially upregulated in bladder cancer cell lines, and inhibition of PDKs combined with cisplatin therapy could further reduce tumor volume in vivo (11). The gene discussed is PDK4; the disease is urinary bladder carcinoma.